Partington MW et al. Familial cutaneous amyloidosis with systemic manifestations in males. Am J Med Genet. 1981;10(1):65-75. PMID: 6794369.
Ades LC et al. An X-linked reticulate pigmentary disorder with systemic manifestations: report of a second family. Pediatr Dermatol. 1993;10(4):344-51. PMID: 8302737.
Anderson RC et al. X-linked reticulate pigmentary disorder with systemic manifestations: report of a third family and literature review. Pediatr Dermatol. 2005;22(2):122-6. PMID: 15804299.
Fernandez-Guarino M et al. X-linked reticulate pigmentary disorder: report of a new family. Eur J Dermatol. 2008;18(1):102-3. PMID: 18086616.
Fraile G et al. Cryptogenic multifocal ulcerous stenosing enteritis (CMUSE) in a man with a diagnosis of X-linked reticulate pigmentary disorder (PDR). Scand J Gastroenterol. 2008;43(4):506-10. PMID: 18365917.
Pezzani L et al. X-linked reticulate pigmentary disorder with systemic manifestations: a new family and review of the literature.Am J Med Genet A. 2013;161A(6):1414-20. PMID: 23613254.
Starokadomskyy P et al. DNA polymerase-alpha regulates the activation of type I interferons through cytosolic RNA:DNA synthesis.Nat Immunol. 2016;17(5):495-504. PMID: 27019227.
Starokadomskyy P et al. Evolution of the skin manifestations of X-linked pigmentary reticulate disorder.Br J Dermatol. 2017;177(5):e200-e201. PMID: 28407217.
Starokadomskyy P et al. NK cell defects in X-linked pigmentary reticulate disorder.JCI Insight. 2019;4(21). PMID: 31672938.
